Scarica l'app Stockscreener
6.50
1.40%
0.09
Precedente Chiudi:
$6.41
Aprire:
$6.49
Volume 24 ore:
566.03K
Relative Volume:
0.84
Capitalizzazione di mercato:
$825.68M
Reddito:
$193.01M
Utile/perdita netta:
$-12.15M
Rapporto P/E:
-162.50
EPS:
-0.04
Flusso di cassa netto:
$454.00K
1 W Prestazione:
+6.04%
1M Prestazione:
+38.59%
6M Prestazione:
+9.06%
1 anno Prestazione:
-4.41%
Intervallo 1D:
$6.4023
$6.56
Intervallo di 1 settimana:
$6.02
$6.83
Portata 52W:
$4.66
$9.87
Cytek Biosciences Inc Stock (CTKB) Company Profile
Nome
Cytek Biosciences Inc
Settore
Industria
Telefono
(877) 922-9835
Indirizzo
47215 LAKEVIEW BOULEVARD, FREMONT
Confronta CTKB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
6.50 | 825.68M | 193.01M | -12.15M | 454.00K | -0.04 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-07-19 | Iniziato | Raymond James | Mkt Perform |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
Cytek Biosciences Inc Borsa (CTKB) Ultime notizie
Cytek Biosciences stock target cut, overweight on revised estimates - Investing.com
Cytek Biosciences stock target cut, overweight on revised estimates By Investing.com - Investing.com Canada
Cytek Biosciences, Inc. (NASDAQ:CTKB) Shares Bought by GSA Capital Partners LLP - Defense World
Principal Financial Group Inc. Purchases 23,028 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Brown Capital Management LLC Trims Stock Holdings in Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference - The Manila Times
Cytek Biosciences to Present at Piper Sandler Healthcare Conference 2024 | CTKB Stock News - StockTitan
Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program - GlobeNewswire
Cytek Biosciences Crowned 2024 BioTech Company of the Year, Leading in Flow Cytometry | CTKB Stock News - StockTitan
Cytek Biosciences (NASDAQ:CTKB) Shares Gap DownShould You Sell? - MarketBeat
Learn to Evaluate (CTKB) using the Charts - Stock Traders Daily
Cytek Biosciences, Inc. (NASDAQ:CTKB) Sees Significant Decrease in Short Interest - MarketBeat
Brown Capital Management LLC Adjusts Stake in Cytek Biosciences Inc - GuruFocus.com
Piper Sandler Forecasts Strong Price Appreciation for Cytek Biosciences (NASDAQ:CTKB) Stock - Defense World
CTKBCytek Biosciences, Inc. Latest Stock News & Market Updates - StockTitan
Cytek Biosciences Inc. (CTKB) Quarterly 10-Q Report - Quartzy
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter - GlobeNewswire
Cytek Biosciences, Inc. (NASDAQ:CTKB) Q3 2024 Earnings Call Transcript - Insider Monkey
Investors Still Aren't Entirely Convinced By Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Revenues Despite 46% Price Jump - Simply Wall St
Cytek Biosciences Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Cytek Biosciences (NASDAQ:CTKB) Shares Up 26.7% After Strong Earnings - Defense World
Earnings call: Cytek Biosciences reports steady growth in Q3 2024 By Investing.com - Investing.com South Africa
Earnings call: Cytek Biosciences reports steady growth in Q3 2024 - Investing.com India
Cytek Biosciences (NASDAQ:CTKB) Shares Up 26.7% After Earnings Beat - MarketBeat
U.S. Stock market: SONN(+86.46%), DataChat(+50.28%), Cytek Biosciences(+30.51%) among the top gainers during early trading - Business Upturn
Cytek Biosciences Inc (CTKB) Q3 2024 Earnings Call Highlights: Revenue Growth and Positive Net ... By GuruFocus - Investing.com Canada
Cytek Biosciences Reports Third Quarter 2024 Financial Results - GlobeNewswire
Cytek Biosciences’ Q3 2024 Financial Highlights - TipRanks
Cytek Biosciences, Inc. (CTKB) Q3 Earnings and Revenues Beat Estimates - MSN
Cytek Biosciences earnings matched, revenue topped estimates - Investing.com
Cytek Biosciences Inc (CTKB) Q3 2024 Earnings: Revenue Hits $51. - GuruFocus.com
Cytek Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Preview: Cytek Biosciences's Earnings - Benzinga
What To Expect From Cytek Biosciences Inc (CTKB) Q3 2024 Earnings - Yahoo Finance
November 2024's Top US Penny Stocks With Growth Potential - Simply Wall St
Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Cytek Biosciences (CTKB) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024 - GlobeNewswire
Cytek® Biosciences automates panel design with new intelligent algorithm - MSN
Layoff Tracker: Dublin-Based CRO With US Offices Signals Upcoming Layoffs - BioSpace
(CTKB) Trading Report - Stock Traders Daily
The Manufacturers Life Insurance Company Purchases 2,460 Shares of Cytek Biosciences, Inc. (NASDAQ:CTKB) - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Short Interest Up 5.4% in September - MarketBeat
Institutional investors have a lot riding on Cytek Biosciences, Inc. (NASDAQ:CTKB) with 53% ownership - Simply Wall St
What technical indicators reveal about CTKB stock - US Post News
Cytek BioSciences Inc (CTKB) Becoming More Attractive for Investors - Knox Daily
Millennium Management LLC Raises Stake in Cytek Biosciences, Inc. (NASDAQ:CTKB) - MarketBeat
Cytek Biosciences (NASDAQ:CTKB) Shares Up 3.6%Still a Buy? - MarketBeat
Analysts review Cytek BioSciences Inc’s rating - Knox Daily
Examining Cytek BioSciences Inc (CTKB) more closely is necessary - US Post News
Quarterly Snapshot: Quick and Current Ratios for Cytek BioSciences Inc (CTKB) - The Dwinnex
Cytek Biosciences Inc Azioni (CTKB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Cytek Biosciences Inc Azioni (CTKB) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Apr 09 '24 |
Sale |
7.00 |
1,900 |
13,304 |
6,008,502 |
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Mar 18 '24 |
Sale |
6.77 |
20,000 |
135,400 |
6,030,402 |
| Yan Ming | CHIEF TECHNOLOGY OFFICER |
Mar 19 '24 |
Sale |
6.71 |
20,000 |
134,200 |
6,010,402 |
| Jeanmonod Patrik | Chief Financial Officer |
Dec 26 '23 |
Sale |
9.50 |
3,000 |
28,500 |
93,400 |
| Yan Ming | Chief Technology Officer |
Dec 19 '23 |
Sale |
9.43 |
20,000 |
188,600 |
6,042,103 |
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):